Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026
Lyon (France), November 4, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its nine-month 2026 financial results on Tuesday, November 24, 2026. The Company will host a live webcast …